Page 5,701«..1020..5,7005,7015,7025,703..5,7105,720..»

Scientist Uses Stem Cell Technology for Anti-Aging Skin Care

Posted: Published on February 16th, 2013

Harvesting human stem cells for scientific advancements continues to provoke ethical questions and controversies. However, scientists continue to find new ways to use stem cells derived from fruit and plants in formulating thier skin care products such as found in the Vargas Cosmetics' Tilth Beauty brand. Monroe, CT (PRWEB) February 15, 2013 This plant contains adaptogens which has shown to protect, nurture and heal damaged cells. The Edelweiss plant (Liontopodium alpinum) is a scarce short-lived mountain flower found sporadically around rocky limestone areas at about 1800-3000 meters in altitude and is frequently associated with the Swiss Alps. This flowers protective characteristics contribute to its organic anti-aging properties. Edelweiss stem cells are shown to visible reduce signs of aging, provide significant antioxidant benefits, and limit degradation of skin collagen and firmness. Skin care scientist and founder of Vargas Cosmetics, Anthony Vargas, uses Edelweiss Stem Cells for Eye Wondrous Serum, which is part of his Tilth Beauty premium anti-aging skin care line. This advanced eye serum formulation also includes potent peptides, encapsulated retinol, along with a plethora of other proven botanical and scientific ingredients. The serums synergy of anti-aging ingredients visibly reduces the appearance of wrinkles, while improving hydration, elasticity and firmness … Continue reading

Posted in Stem Cell Research | Comments Off on Scientist Uses Stem Cell Technology for Anti-Aging Skin Care

International Stem Cell Corporation Strengthens Intellectual Property Portfolio

Posted: Published on February 16th, 2013

CARLSBAD, CA--(Marketwire - Feb 15, 2013) - International Stem Cell Corporation ( OTCQB : ISCO ) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company, today announced amendments to the license agreements with Advanced Cell Technology, Inc. The license agreements, first entered into in 2004 and amended in 2005, granted ISCO access to a range of ACT's patents and patent applications for the use of various technologies in a limited set of human tissues. The amendments extend ISCO's existing rights in the area of parthenogenesis, and the therapeutic use of parthenogenetically derived stem cells for treating any human diseases. Pursuant to the amended agreements ISCO now has an exclusive world-wide license to ACT's patents and applications covering the uses of parthenogenetically derived stem cells in generating human tissue. "We're excited to have extended our portfolio of intellectual property which not only allows us to develop new therapeutic and business opportunities, but also makes the possibility of partnering with big pharma practical," commented Dr. Andrey Semechkin, CEO and Co-Chairman of ISCO. About International Stem Cell CorporationInternational Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic … Continue reading

Posted in Stem Cell Research | Comments Off on International Stem Cell Corporation Strengthens Intellectual Property Portfolio

Researchers uncover new findings on genetic risks of Behçet's disease

Posted: Published on February 16th, 2013

Public release date: 15-Feb-2013 [ | E-mail | Share ] Contact: Beata Mostafavi bmostafa@umich.edu 734-764-2220 University of Michigan Health System ANN ARBOR, Mich. Researchers don't know the exact cause of Behet's disease, a chronic condition that leads to oral and genital sores and serious complications such as blindness, but new research brings better understanding to what makes some people more susceptible to being affected. In one of the most extensive genetic analyses of Behet's disease, a University of Michigan-led, international team of researchers has identified novel gene variants in the inflammatory disorder and uncovered data that could apply to studies of other diseases. The results appear in the journal Nature Genetics. "This disease is associated with significant complications and because it is not well understood, treatment options are limited," says lead author Amr Sawalha, M.D., associate professor of internal medicine in the division of rheumatology at the U-M Medical School. "We were able to identify and localize robust genetic risk factors associated with Behet's disease in a way that will hopefully bring us a step closer to better understanding this devastating illness." The UMHS research, a collaboration that includes researchers from Turkey, Italy, Germany and the Netherlands, identifies how a … Continue reading

Comments Off on Researchers uncover new findings on genetic risks of Behçet's disease

Researchers Uncover New Findings on Genetic Risks of Chronic Inflammatory Disorder Behcet's Disease

Posted: Published on February 16th, 2013

Newswise ANN ARBOR, Mich. Researchers dont know the exact cause of Behet's disease, a chronic condition that leads to oral and genital sores and serious complications such as blindness, but new research brings better understanding to what makes some people more susceptible to being affected. In one of the most extensive genetic analyses of Behet's disease, a University of Michigan-led, international team of researchers has identified novel gene variants in the inflammatory disorder and uncovered data that could apply to studies of other diseases. The results appear in the journal Nature Genetics. This disease is associated with significant complications and because it is not well understood, treatment options are limited, says lead author Amr Sawalha, M.D., associate professor of internal medicine in the division of rheumatology at the U-M Medical School. We were able to identify and localize robust genetic risk factors associated with Behets disease in a way that will hopefully bring us a step closer to better understanding this devastating illness. The UMHS research, a collaboration that includes researchers from Turkey, Italy, Germany and the Netherlands, identifies how a specific group of genes are linked to Behets disease. The disease can affect people from all ethnicities, but has … Continue reading

Comments Off on Researchers Uncover New Findings on Genetic Risks of Chronic Inflammatory Disorder Behcet's Disease

Dr. Diana Bianchi Presents Data Demonstrating Verinata Health's Proprietary Technology Detects Genetic Abnormalities …

Posted: Published on February 16th, 2013

REDWOOD CITY, Calif., Feb. 15, 2013 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today presented data demonstrating its approach to detect aneuploidies in maternal blood from multiple gestation pregnancies. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) Contrary to previous study findings by other investigators, this study demonstrated that each fetus in twin pregnancies contributes approximately 50 percent less cell-free fetal DNA to a maternal blood sample when compared to the cell-free DNA makeup of singleton pregnancies. As a result of this reduced fetal fraction, deeper sequencing is necessary to determine if a chromosome abnormality is or is not present in one or both of the fetuses with a high degree of confidence. "While we were able to correctly detect aneuploidy in twin pregnancies with a sequencing depth similar to that currently implemented for singleton pregnancies, deeper sequencing offers better resolution and discrimination for these complex samples," said Richard Rava, Ph.D., Chief Scientific Officer of Verinata Health."Thus, it may reduce the number of false negatives and increase the confidence in the results for multiple gestation pregnancies." The analysis included 85 maternal plasma samples that were previously excluded from Verinata's large, blinded, prospective validation study of singleton pregnancies. The full … Continue reading

Comments Off on Dr. Diana Bianchi Presents Data Demonstrating Verinata Health's Proprietary Technology Detects Genetic Abnormalities …

Stem Cell Surgery Study by Dr. Ruth Roberts of SDCM – Kidney Disease – Video

Posted: Published on February 16th, 2013

Stem Cell Surgery Study by Dr. Ruth Roberts of SDCM - Kidney Disease STEM CELL TRANSPLANT STUDY IN CATS AND DOGS POINTS TO GROUNDBREAKING TREATMENT FOR KIDNEY DISEASE Sabrina is a fourteen-year-old cat, diagnosed with kidney disease. Yet, Sabrina's luck has changed due to a groundbreaking study in cats and dogs for the treatment of kidney disease. The research study by Dr. Ruth Roberts with Sun Dog Cat Moon Veterinary Clinic (SDCM) is stem cell transplant surgery. Sabrina's procedure was on January 21, 2013. During surgery, stem cells were harvested from a four-ounce sample of her own fat tissue. "Modified stem cells find their way to the appropriate locations of the damaged kidneys, engrafting themselves into key areas for renal function, resulting in reduced inflammation, allowing regeneration of tissue and improved function in the kidney. There is a need in veterinary medicine for a regenerative treatment in kidney failure," says Dr. Ruth Roberts. For more information on Dr. Ruth Roberts' study on stem cell therapy for chronic renal failure in cats and dogs, please contact SDCM at 843-437-0063 and info@SunDogCatMoon.com Visit http://www.SunDogCatMoon.com Dr. Ruth Roberts DVM / CVA / CVH 843-437-0063 Info@SunDogCatMoon.com For media: Penelope Jean Publicist … Continue reading

Comments Off on Stem Cell Surgery Study by Dr. Ruth Roberts of SDCM – Kidney Disease – Video

Muscular Dystrophy Improvement seen in just 4 days – Video

Posted: Published on February 16th, 2013

Muscular Dystrophy Improvement seen in just 4 days He is a known case of MD with history of gradual onset of lower extremities muscle weakness noticed since age of 12 years with complaints of footwear slipping, frequent falling, difficulty in stairs climbing and getting up from floor. Gradually weakness progressed to upper extremities with difficulty in overhead activities. He even reports difficulty in pronunciation of "Ra", "La". He has no family history of MD. Functionally, he is modified independent in all ADL and mobility. On FIM he scores 79. After Stem Cell Treatment 1. Feels more energetic. Stamina has improved. 2. Sitting posture has improved. 3. Walking and standing posture is more erect. 4. Balance while walking has improved. 5. He can maintain kneeling position. 6. Bending and rotation from trunk is easier because of increase in back extensor strength. 7. Slow rate of speech achieved. 8. Lisping reduced. 9. Correct articulation for fricatives /s/, /sh/ and velar /ksha/ achieved in isolation. Stem Cell Therapy done at Dr Alok Shrama NeuroGen Brain and Spine Institute Surana Sethia Hospital Sion-Trombay Rd, Suman Ngr Opp Corporate Park, Chembur, Mumbai -- 71. Tel : 022 - 25283706, 022 - 25281610, Mob : +91 … Continue reading

Comments Off on Muscular Dystrophy Improvement seen in just 4 days – Video

Get younger-looking skin

Posted: Published on February 16th, 2013

By Daniela Dadurian, M.D. Question: What is Stem Cell Facial Therapy? Answer: Stem cell therapy has been used by doctors since as early as the 16th century to heal damaged cells or tissue. Only for about a decade have we started using this process again in modern medicine instead of medications that use chemicals to treat illness and/or suppress it. A new Stem Cell Facial Therapy uses stem cells derived from sheeps placenta. The placenta and umbilical cord tissue cells are ethically harvested from sheep, post birth, so there is absolutely no harm to animals. The pluripotent stem cells are extremely nutrient and very similar to embryonic stem cells, which means that they have the ability to repair every type of cell in the body. When applied in sufficient concentrations, large numbers of bio-active stem cells immediately de-age the skin by stimulating the dermal layer to produce increased levels of collagen and elastic fibers. This can be described as skin food that provides cellular renewal and reduces inflammation and hydrates the skin. This results in thicker, younger-looking skin. For more information, call (561) 655-6325. Daniela Dadurian, M.D., specializes in anti-aging medicine and is an expert in non-surgical body contouring techniques. … Continue reading

Comments Off on Get younger-looking skin

Gazette.Net: United Therapeutics heads back to the FDA

Posted: Published on February 16th, 2013

Four months after the Food and Drug Administration shot down United Therapeutics application to market a tablet version of its drug for pulmonary arterial hypertension, the Silver Spring company has reapplied to the regulatory agency. United Therapeutics, which already sells intravenous, subcutaneous and inhaled versions of its major money-maker, has been working for years to gain regulatory approval for an oral version. United Therapeutics stock rose 5.5 percent Thursday morning on the news; it had tumbled 15.3 percent following the FDAs rejection in October. At the time, the FDA said it had concerns that the drug, called oral trepostinil, didnt show enough improvement in patients who took it in clinical trials, as measured by how far they could walk in six minutes. The agency suggested that another phase 3 trial should possibly involve fixed and more frequent dosing, such as three times a day versus twice daily, COO Roger Jeffs said in a conference call then. Some of the agencys concerns came as a surprise, Jeffs said, as they hadnt been raised in regulators discussions with the company. Since then, company officials have met with regulators to gain a better understanding of their concerns, and the resubmitted application addresses those … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Gazette.Net: United Therapeutics heads back to the FDA

FDA Approves First Bionic Eye

Posted: Published on February 16th, 2013

Second Sight Medical Products / AP This undated product image provided by Second Sight Medical Products shows a new implantable device that takes the place of damaged cells inside the eye. It wont restore sight completely, but allows sight-impaired individuals to detect light and dark. On Thursday, the U.S. Food and Drug Administration (FDA) approved a device created by Second Sight Medical Products that can be used to treat a rare type of blindness calledretinitis pigmentosa (RP). Retinitis pigmentosa isa genetic eye condition in which cells of the retina, which are responsible for translating light rays into images in the brain, gradually deteriorate. People with the condition start to lose peripheral vision first, then find it harder to see at night until eventually their central vision is lost as well. According to the national statistics, about one in 4000 people in the U.S. are affected by RP. (MAGAZINE: The High-Tech Future of the Human Body) The artificial retina, called the Argus II Retinal Prosthesis System, is the first implantable device to treat the condition and is approved for people over age 25 with advanced RP who can see some light. The device consists of a panel of electrodes that are … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on FDA Approves First Bionic Eye

Page 5,701«..1020..5,7005,7015,7025,703..5,7105,720..»